Oncology Tube· @oncologytube · X·· 2026-04-20Score60
Reading
KRAS / RAS targeting: from platform to Phase 3
zoldonrasib and VS-7375 in G12D remain Phase 1 — strong numbers, small samples, not head-to-head.
Body
@AACR
Press Conference 1 Highlights from #AACR26 dropping soon!
http://
OncologyTube.com
Moderated by Jayesh Desai, MD (Peter MacCallum Cancer Centre)
Featuring:
Investigational KRAS(ON) Inhibitor Zoldonrasib Showed Effective and Durable Responses in Patients With
Heat 4 · 2 likes · 0 replies · 2 reposts
Source: Oncology Tube · x.com